Medical Oncology

Doç. Dr. Abdilkerim Oyman

Doctor and researcher İstinye Üniversitesi Gaziosmanpaşa Hastanesi İstanbul
Breast NeoplasmsAdenocarcinomaRectal NeoplasmsColorectal NeoplasmsStomach Neoplasms
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Breast Neoplasms 4 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Adenocarcinoma 3 publications
  • Rectal Neoplasms 2 publications
  • Colorectal Neoplasms 2 publications
  • Stomach Neoplasms 2 publications

Person ↔ Disease

Which topics does this doctor work on?

From source

Medical areas of interest stated by the doctor on the institution profile. Source: medicalpark.com.tr.

  • Meme Kanseri
  • Akciğer Kanseri
  • Kolon Kanseri
  • Prostat kanseri
  • Böbrek Kanseri
  • İmmünoterapi
  • Kadın Kanserleri Over Endometrium Serviks Hedefe Yönelik Tedaviler

CV

Education and experience

From source

Experience

  • 20102014 Trakya Üniversitesi Tıp Fakültesi Hastanesi İç Hastalıkları Hastalıkları Kliniği,medicalpark.com.tr
  • 20152018 Kartal Dr. Lütfi Kırdar Eğitim ve Araştırma Hastanesi Tıbbi Onkolojimedicalpark.com.tr
  • 20182023 Sağlık Bilimleri Üniversitesi Ümraniye EAH Tıbbi Onkolojimedicalpark.com.tr
  • 2023Özel Gaziosmanpaşa Hastanesimedicalpark.com.tr

Education

  • 20022008 Trakya Üniversitesi Tıp Fakültesi, Dr.medicalpark.com.tr
  • 20222023 Sağlık Bilimleri Üniversitesi Ümraniye EAH Doç. Dr.medicalpark.com.tr

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyMedical Oncologymedicalpark.com.trFrom source
  • Department name at the sourceMedikal Onkoloji (Tıbbi Onkoloji)medicalpark.com.trFrom source
  • Institutionİstinye Üniversitesi Gaziosmanpaşa Hastanesimedicalpark.com.trFrom source
  • Area of workBreast NeoplasmsExtracted from 4 publications · Model version —From source
  • Publications32 publicationsOpenAlex, ORCIDFrom source
  • ORCID0000-0002-2291-7544ORCIDFrom source
  • Last synchronised4 November 2026 20:31https://www.medicalpark.com.tr/hekimler/abdilkerim-oymanmedicalpark.com.tr

Scientific work

Publications on Breast Neoplasms

32 publications

  1. Impact of HER2-Low Expression on Clinical Outcomes in Metastatic Breast Cancer Treated with CDK4/6 Inhibitors

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15051898 PMID 41827314 Open-access full textSource: OpenAlex

  2. Meme Kanseri

    Akademisyen Kitabevi eBooks, 2026

    DOI 10.37609/akya.3852 Open-access full textSource: OpenAlex

  3. Comparative Prognostic Value of Systemic Inflammation-Based Biomarkers in Advanced Non-Small Cell Lung Cancer Treated with First-Line Immunotherapy

    Biomedicines, 2026

    DOI 10.3390/biomedicines14081825 PMID 42652206 Open-access full textSource: OpenAlex

  4. Prognostic Impact of the Lung Immune Prognostic Index in Metastatic Non-Small Cell Lung Cancer Patients Treated with Nivolumab

    Cancers, 2026

    DOI 10.3390/cancers18071170 PMID 41976392 Open-access full textSource: OpenAlex

  5. Nadir Görülen Meme Kanseri Alt Tipleri

    Akademisyen Kitabevi eBooks, 2026

    DOI 10.37609/akya.3852.c2805 Source: ORCID

  6. Clinicopathological Predictors of Axillary Pathological Complete Response and Its Prognostic Significance in Clinically Node-Positive (cN+), HER2-Positive Breast Cancer Following Neoadjuvant Therapy

    Medicina, 2026

    DOI 10.3390/medicina62010200 PMID 41597486 Open-access full textSource: OpenAlex

  7. Comparison of the efficacy of mFOLFOX-6 and mDCF regimens in the treatment of metastatic gastric cancer: a multicenter retrospective study

    Therapeutic Advances in Medical Oncology, 2025

    DOI 10.1177/17588359251368069 PMID 40900677 5 citations (Europe PMC) Open-access full textSource: OpenAlex

  8. Long-Term Oncological Outcomes for Locally Advanced Rectal Cancer Patients with Pathological Complete Response After Neoadjuvant Chemoradiotherapy: A Turkish Oncology Group Study

    Cancer Investigation, 2025

    DOI 10.1080/07357907.2025.2595536 PMID 41347635 1 citation (Europe PMC) Source: OpenAlex

  9. Can Cytoreductive Nephrectomy Improve Outcomes of Nivolumab Treatment in Patients with Metastatic Clear-Cell Renal Carcinoma?

    Current Oncology, 2024

    DOI 10.3390/curroncol31090384 PMID 39330012 Open-access full textSource: OpenAlex

  10. Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy

    BMC Cancer, 2023

    DOI 10.1186/s12885-023-10609-8 PMID 36765293 18 citations (Europe PMC) Open-access full textSource: OpenAlex

View all 32 publications